Correlation Between Aerovate Therapeutics and Premier Information

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Premier Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Premier Information into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Premier information Management, you can compare the effects of market volatilities on Aerovate Therapeutics and Premier Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Premier Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Premier Information.

Diversification Opportunities for Aerovate Therapeutics and Premier Information

-0.58

Correlation Coefficient

Aerovate Therapeutics  Premier Information

Excellent diversification

The 3 months correlation between Aerovate and Premier is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Premier information Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Premier information and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Premier Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Premier information has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Premier Information go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Premier Information

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 7.71 times less return on investment than Premier Information. But when comparing it to its historical volatility, Aerovate Therapeutics is 11.73 times less risky than Premier Information. It trades about 0.16 of its potential returns per unit of risk. Premier information Management is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.30  in Premier information Management on September 12, 2024 and sell it today you would lose (0.21) from holding Premier information Management or give up 70.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Premier information Management

Aerovate Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Premier information

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Premier information Management are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain technical and fundamental indicators, Premier Information reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Premier Information

The main advantage of trading using opposite Aerovate Therapeutics and Premier Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Premier Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Premier Information will offset losses from the drop in Premier Information's long position.

The idea behind Aerovate Therapeutics and Premier information Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.